BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31916360)

  • 1. Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort.
    Gaete MI; Díaz LA; Arenas A; González K; Cattaneo M; Fuster F; Henríquez R; Soza A; Arrese M; Barrera F; Arab JP; Benítez C
    Liver Int; 2020 Jun; 40(6):1427-1434. PubMed ID: 31916360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
    Petta S; Sebastiani G; Bugianesi E; Viganò M; Wong VW; Berzigotti A; Fracanzani AL; Anstee QM; Marra F; Barbara M; Calvaruso V; Cammà C; Di Marco V; Craxì A; de Ledinghen V
    J Hepatol; 2018 Oct; 69(4):878-885. PubMed ID: 29802949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various etiologies.
    Nawalerspanya S; Sripongpun P; Chamroonkul N; Kongkamol C; Piratvisuth T
    Ann Hepatol; 2020; 19(2):209-213. PubMed ID: 31607647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of three "beyond Baveno VI" criteria to safely spare endoscopies in compensated advanced chronic liver disease.
    Tosetti G; Primignani M; La Mura V; D'Ambrosio R; Degasperi E; Mezzina N; Viganò M; Rumi M; Fracanzani AL; Lombardi R; Fargion S; Fraquelli M; Aghemo A; Lampertico P
    Dig Liver Dis; 2019 Aug; 51(8):1135-1140. PubMed ID: 30691777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Baveno VI and Expanded-Baveno VI Criteria for predicting gastroesophageal varices in patients with alcoholic and non-alcoholic fatty liver disease.
    Pizzamiglio M; Weicker A; de Terwangne C; Henrion J; Descamps OS; De Vos M
    Acta Gastroenterol Belg; 2022; 85(2):321-329. PubMed ID: 35709776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.
    Galizzi HO; Couto CA; Taranto DOL; Araújo SIO; Vilela EG
    Ann Hepatol; 2021; 20():100229. PubMed ID: 32745630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baveno criteria perform better than expanded Baveno and Rete Sicilia Selezione Terapia-Hepatitis C virus criteria for predicting varices needing treatment.
    Agarwal A; Pathak P; Gupta S; Kumar R; Shalimar
    Indian J Gastroenterol; 2021 Dec; 40(6):590-597. PubMed ID: 33991311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.
    Augustin S; Pons M; Maurice JB; Bureau C; Stefanescu H; Ney M; Blasco H; Procopet B; Tsochatzis E; Westbrook RH; Bosch J; Berzigotti A; Abraldes JG; Genescà J
    Hepatology; 2017 Dec; 66(6):1980-1988. PubMed ID: 28696510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
    Merchante N; Saroli Palumbo C; Mazzola G; Pineda JA; Téllez F; Rivero-Juárez A; Ríos-Villegas MJ; Maurice JB; Westbrook RH; Judge R; Guaraldi G; Schepis F; Perazzo H; Rockstroh J; Boesecke C; Klein MB; Cervo A; Ghali P; Wong P; Petta S; De Ledinghen V; Macías J; Sebastiani G
    Clin Infect Dis; 2020 Dec; 71(11):2810-2817. PubMed ID: 31813962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease.
    Colecchia A; Ravaioli F; Marasco G; Colli A; Dajti E; Di Biase AR; Bacchi Reggiani ML; Berzigotti A; Pinzani M; Festi D
    J Hepatol; 2018 Aug; 69(2):308-317. PubMed ID: 29729368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
    Moctezuma-Velazquez C; Saffioti F; Tasayco-Huaman S; Casu S; Mason A; Roccarina D; Vargas V; Nilsson JE; Tsochatzis E; Augustin S; Montano-Loza AJ; Berzigotti A; Thorburn D; Genesca J; Abraldes JG
    Am J Gastroenterol; 2019 Mar; 114(3):446-452. PubMed ID: 30315285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
    Thabut D; Bureau C; Layese R; Bourcier V; Hammouche M; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Goria O; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle-Bladou C; Dao T; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Hillaire S; Di Martino V; Sutton A; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2019 Mar; 156(4):997-1009.e5. PubMed ID: 30768988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy.
    Bae J; Sinn DH; Kang W; Gwak GY; Choi MS; Paik YH; Lee JH; Koh KC; Paik SW
    Liver Int; 2018 Aug; 38(8):1442-1448. PubMed ID: 29495113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Baveno VI criteria to rule out high-risk varices using hepatic shear-wave elastography.
    Castro Filho ÉC; Fernandes FF; Villela-Nogueira C; Madeira E; Barros F; Luz R; Pereira GH; Perazzo H
    Eur J Gastroenterol Hepatol; 2023 May; 35(5):559-567. PubMed ID: 36966754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciding Among Noninvasive Tools for Predicting Varices Needing Treatment in Chronic Liver Disease: An Analysis of Asian Cohort.
    Sharma S; Agarwal S; Gunjan D; Kaushal K; Anand A; Saraya A
    Am J Gastroenterol; 2020 Oct; 115(10):1650-1656. PubMed ID: 32516202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices.
    Maurice JB; Brodkin E; Arnold F; Navaratnam A; Paine H; Khawar S; Dhar A; Patch D; O'Beirne J; Mookerjee R; Pinzani M; Tsochatzis E; Westbrook RH
    J Hepatol; 2016 Nov; 65(5):899-905. PubMed ID: 27388923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis.
    Jangouk P; Turco L; De Oliveira A; Schepis F; Villa E; Garcia-Tsao G
    Liver Int; 2017 Aug; 37(8):1177-1183. PubMed ID: 28160373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baveno VII criteria identify varices needing treatment in patients with hepatocellular carcinoma of different Barcelona Clinic Liver Cancer stages.
    Wu CW; Wong GL; Wong VW; Yam TF; Yip TC; Wong AC; Chan BW; Fong MM; Lai JC; Tse YK; Lee KF; Mok TS; Chan HL; Lui RN; Chan SL; Ng KK
    J Gastroenterol Hepatol; 2023 Aug; 38(8):1381-1388. PubMed ID: 37218373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baveno VI criteria and spleen stiffness measurement rule out high-risk varices in virally suppressed HBV-related cirrhosis.
    Wang H; Wen B; Chang X; Wu Q; Wen W; Zhou F; Guo Y; Ji Y; Gu Y; Lai Q; He Q; Li J; Chen J; Hou J
    J Hepatol; 2021 Mar; 74(3):584-592. PubMed ID: 33039403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease.
    Lee HA; Kim SU; Seo YS; Lee YS; Kang SH; Jung YK; Kim MY; Kim JH; Kim SG; Suk KT; Jung SW; Jang JY; An H; Yim HJ; Um SH
    Liver Int; 2019 Jun; 39(6):1071-1079. PubMed ID: 30589490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.